General Information of the Compound
Compound ID
CP0462913
Compound Name
4-(3-pyridylethynyl)-2-thiazolylamine
    Show/Hide
Synonyms
329205-54-1
4-(3-pyridylethynyl)-2-thiazolylamine
CHEMBL381031
SCHEMBL4158461
    Show/Hide
Structure
Formula
C10H7N3S
Molecular Weight
201.254
Canonical SMILES
Nc1nc(cs1)C#Cc1cccnc1
    Show/Hide
InChI
InChI=1S/C10H7N3S/c11-10-13-9(7-14-10)4-3-8-2-1-5-12-6-8/h1-2,5-7H,(H2,11,13)
    Show/Hide
InChIKey
BQUGCIBMYSKXRH-UHFFFAOYSA-N
Physicochemical Property
logP
1.5201
Rotatable Bonds
0
Heavy Atom Count
14
Polar Areas
51.8
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
4
Complexity
14

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 11564671
SID: 16666862
ChEMBL ID
CHEMBL381031
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00854, Metabotropic glutamate receptor 5
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000011 CHO Cricetulus griseus (Chinese hamster)  1
1
IC50 = 789 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( 4-(3-pyridylethynyl)-2-thiazolylamine )
Drug Name 4-(3-pyridylethynyl)-2-thiazolylamine
Target(s)
Metabotropic glutamate receptor 5 (mGluR5)
Inhibitor